- Previous Rank-
- Revenue 3 Yr Annual Growth Rate18%
- Revenue 3 Yr Growth Rank85
- EPS 3 Yr Annual Growth Rate67%
- EPS 3 Yr Growth Rank21
- Total Return 3 Yr Annual Rate22%
- Total Return 3 Yr Rank55
As complexity grows for clinical trials and studies, Medidata, which makes cloud-based software to help automate them, is profiting handsomely.
Company Information
Revenue and net income for the four quarters ended on or before April 30, 2017. Total return for the period ended June 30, 2017.
| Location | New York, N.Y. |
| Industry | Health Care: Pharmacy and Other Services |
| Sector | Health Care |
| Current Streak | - |
| Years on List | 1 |
| CEO | Tarek Sherif |
| Website | http://www.mdsol.com |
Looking for leads, investment insights, or competitive intelligence?Purchase Now
Revenue, Net Income
| Revenue past four quarters ($M) | $486 |
| Net Income past four quarters ($M) | $34 |
Growth Rates and Ranks
| Revenue 3 Yr Growth Rank | 85 |
| Revenue 3 Yr Annual Growth Rate | 18% |
| EPS 3 Yr Growth Rank | 21 |
| EPS 3 Yr Annual Growth Rate | 67% |
| Total Return 3 Yr Rank | 55 |
| Total Return 3 Yr Annual Rate | 22% |
| Beat S&P 500 (9.6%) | yes |
| P/E Ratio | 99 |